THE QUALITY OF THE INFORMATION FIELD OF DOCTORS AS A CONDITION OF THE EFFECTIVENESS OF THEIR DECISIONS

Author(s):  
Nerobeev A.S ◽  
Brovtsev O.V. ◽  
Abrosimov E.A.

A multicenter study was conducted on the basis of medi-cal organizations in the Ivanovsk and Vladimir regions in order to study the quality of the information field of doc-tors of different specialities and assess its impact on the effectiveness of medical decisions. 400 cases of care were studied and a survey of 400 doctors was conducted. The study showed that the narrowing of the professional in-formation field of most doctors (78,0%) and the low dy-namics of its expansion. The low quality of the infor-mation field of doctors is noteworthy - its limitation is mainly regulatory sources and low innovation compo-nent. This makes it necessary, in the context of the in-creasing volume of information flows, the training of in-formation assistants of doctors - "information managers."

2021 ◽  
pp. medethics-2020-107096
Author(s):  
Waldemar Głusiec

Background and aimsFew Polish hospitals have Hospital Ethics Committee (HECs) and the services are not always adequate. In this situation, the role of HECs, in providing, among others, ethical advice on the discontinuation of persistent therapies, may be taken over by other entities. The aim of our research was to investigate, how often and on what issues hospital chaplains are asked for ethical advice in reaching difficult medical decisions.MethodsA survey of 100 Roman Catholic chaplains was conducted, that is, at least 10% of all chaplains currently working in Polish hospitals.ResultsOf the participants, 29% confirmed receiving requests for advice in making a morally difficult medical decision. Receiving this type of request was not conditional on the place of their service, duration of their pastoral mission or HEC membership. The largest group of chaplains (21%) encounter questions concerning the ethical dilemmas associated with discontinuing persistent therapy. Patients and their families most often raise issues related to the methods of birth control, and the medical staff raise the issue of termination of pregnancy—as reported by 9% and 15% of chaplains, respectively. Most of the chaplains asked for help (79%) experience a deficit of specialist knowledge in the area of medicine or ethics.ConclusionsIn order to improve the quality of ethical consultations in Polish hospitals, in addition to further development of HECs, it is postulated to develop a system for bioethical education of chaplains.


2019 ◽  
Vol 112 (4) ◽  
pp. e137-e152 ◽  
Author(s):  
Kelechi E. Nnoaham ◽  
Lone Hummelshoj ◽  
Premila Webster ◽  
Thomas d'Hooghe ◽  
Fiorenzo de Cicco Nardone ◽  
...  

2020 ◽  
pp. 1-13
Author(s):  
Niels Teich ◽  
Michael Bläker ◽  
Frank Holtkamp-Endemann ◽  
Eric Jörgensen ◽  
Andreas Stallmach ◽  
...  

<b><i>Introduction:</i></b> Infliximab (IFX) therapy is efficacious for inducing and maintaining symptomatic remission in patients with Crohn’s disease (CD), but whether this benefit results in reduced hospitalization rates and therefore may improve patients’ quality of life in an economically sensible way is conflicting so far. <b><i>Methods:</i></b> We conducted a noninterventional, multicenter, open-label, prospective study to evaluate the effect of originator IFX treatment on patient-reported outcomes and disease-related hospitalizations in adult CD patients in Germany treated for the first time with IFX according to label. <b><i>Results:</i></b> Two hundred and ninety-four patients were included in the study. We observed a statistically significant reduction in the number of CD-related hospitalizations from the year before baseline (mean 1.00 per patient, SD ± 0.93) to the mean value of the 1st (0.62, SD ± 0.95) and 2nd year (0.32, SD ± 0.75) of the observation period (<i>p</i> &#x3c; 0.0001). After 3 months of IFX therapy, work productivity and activity increased by an average of 12.6 and 17.1%, respectively. Patient’s clinical outcome was markedly improved as the total CD activity index (CDAI) sum score continuously decreased from baseline to month 24 and the mean score of the total inflammatory bowel disease questionnaire (IBDQ) changed substantially from 141 at baseline to 172 after 24 months of IFX treatment. Additionally, the number of work incapacity days declined. Recently, no new safety issues of IFX have been identified. <b><i>Conclusion:</i></b> In this large, prospective, multicenter study on disease-related hospitalization rates, work productivity, capacity for daily activities, and HRQoL in patients with CD, IFX significantly reduces their hospitalization rates and improves work productivity, daily activity, and quality of life over 24 months.


2005 ◽  
Vol 10 (3) ◽  
pp. 259-268 ◽  
Author(s):  
Irene Aprile ◽  
Pietro Caliandro ◽  
Giuseppe La Torre ◽  
Pietro Tonali ◽  
Mariangela Foschini ◽  
...  

2019 ◽  
Vol 67 (1) ◽  
pp. 197-210 ◽  
Author(s):  
Lara Hvidsten ◽  
Knut Engedal ◽  
Geir Selbæk ◽  
Torgeir Bruun Wyller ◽  
Jūratė Šaltytė Benth ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document